Newspatrolling.com News cum Content Syndication Portal Online
Dr. Dharav Kheradia, Consultant Neuro and Vascular Interventional Radiologist at Wockhardt Hospitals, Mumbai Central
Benign Prostatic Hyperplasia (BPH), a non-cancerous enlargement of the prostate gland, is a common condition affecting men, particularly those over 60. Symptoms such as difficulty initiating urination, weak or interrupted urine flow, frequent night-time urination (nocturia), and a persistent feeling of incomplete bladder emptying can significantly impact quality of life. Accurate diagnosis is essential, as these symptoms may mirror more severe conditions. Advanced diagnostic methods like digital rectal examinations (DRE), ultrasound, Prostate-Specific Antigen (PSA) tests, uroflowmetry, and the International Prostate Symptom Score (IPSS) play a crucial role in crafting tailored treatment plans for patients.
Prostate Artery Embolization (PAE) has emerged as a ground-breaking solution for managing BPH, especially for patients who are unsuitable candidates for traditional surgery due to health risks such as cardiovascular conditions or blood-thinning medications. This minimally invasive procedure involves inserting a small catheter through the femoral artery and using embolic particles to block blood flow to the prostate. By reducing the gland’s size, PAE alleviates symptoms without the risks and extended recovery times associated with surgery.
The advantages of PAE are numerous. The procedure offers substantial symptom relief with minimal recovery time and fewer risks compared to traditional surgical methods. Most patients resume normal activities within days, and long-term effectiveness is high, with only a small percentage requiring repeat intervention.
A notable example involved a 70-year-old man with moderate BPH who experienced frequent nocturia and urinary difficulties. Due to cardiovascular comorbidities, he was not a candidate for conventional surgery. PAE was successfully performed, and within six weeks, the patient reported an 85-90% improvement in symptoms, significantly enhancing his quality of life. He was discharged the same day, and follow-up evaluations confirmed sustained symptom relief.
PAE represents a significant advancement in the treatment of BPH, offering a safer and more effective alternative for patients with comorbidities or those seeking minimally invasive solutions. This innovation highlights the ongoing evolution of medical practices aimed at improving outcomes and enhancing patient care.
